in

Centene may lose sole 4-star Medicare Advantage rating, CEO says

Centene to spend $1.65B to shed real estate holdings

Centene’s standing in the Medicare Advantage market may further deteriorate as the company anticipates losing its sole four-star quality rating, CEO Sarah London told investors Friday.

The insurer reported the greatest drop in star ratings among Medicare Advantage carriers last year after the Centers for Medicare and Medicaid resumed stringent reviews it had paused during the COVID-19 public health emergency. Insurers strive to achieve at…


Posted by Editor

Five Key Questions on Kering and Mayhoola’s Valentino Deal

Five Key Questions on Kering and Mayhoola’s Valentino Deal

US Tightens Export Controls on Advanced Chips, Engine Technology Critical to National Security

Chipmakers Hint at Ease of Chip Supply Glut but Demand Recovery Still Slow